|
Real-time Estimate
Cboe BZX
04:59:54 06/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 7.605 USD | -7.71% |
|
-10.68% | -2.44% |
| 11-05 | BioCryst Pharmaceuticals, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-05 | Wedbush Adjusts BioCryst Pharmaceuticals PT to $17 From $18, Maintains Outperform Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BCRX | Delayed | |
CBOE
| BCRX | Real-time | |
|
Mexican S.E.
| BCRX * | End-of-day quote | |
|
Tradegate
| BO1 | Real-time | |
|
Boerse Muenchen
| BO1 | Real-time | |
|
Deutsche Boerse AG
| BO1 | Delayed | |
|
Börse Stuttgart
| BO1 | Delayed | |
|
Berne S.E.
| BO1 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 8.59 | 9.55 | 10.45 |
| Spread/Res. | -11.41% | -20.31% | -27.18% |
| Spread/Supp. | -0.52% | -0.52% | +19.28% |
| Support | 7.65 | 7.65 | 6.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BCRX Stock
- Charts BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
